retatrutide dosing in clinical trials VisualAbstract: reduces body weight by 17.5% patients with obesity Retatrutide Dosing Guide: 1-12 mg

4.4.1 Clinical evidence and limitations An open-label RCT compared 12 weeks of MET versus MET + low-dose liraglutide (1.2 mg/d) as pretreatment before IVF in obese infertile women (with a 4-weeks washout)

(synthetic GLP-1) Natural vs Synthetic GLP-1 Peptides are naturally produced in your body including GLP-1

The FDA has stated explicitly that "retatrutide and cagrilintide cannot be used in compounding under federal law." The reason is that retatrutide does not appear on the 503A bulks list, is not a component of any FDA-approved drug, and does not have an applicable USP or NF monograph

ensure electrolytes

Consider joining today

Half-Life: ~6 Days Retatrutide has a terminal half-life of approximately 6 days, meaning half of the drug is eliminated from your body every 6 days